openPR Logo
Press release

Anticoagulant Rodenticides Market Will Grow USD 921.56 Million By 2030 | CAGR: 3.5%

Anticoagulant Rodenticides Market

Anticoagulant Rodenticides Market

The global anticoagulant rodenticides market size is expected to reach USD 921.56 million by 2030 according to a new study by Polaris Market Research.

The increased demand for mosquito control solutions to reduce the growing rodent population and efforts to stop illness caused by them are driving the market expansion. For instance, Rentokil PCI provides a call-out solution for rats and other pest control issues in the home. Also, according to the CDC, rats and mice are responsible for the transmission of over 35 diseases worldwide. These infections are spread to people through direct communication with rodents, feces, urine, or saliva, or through rodent bites. Infections transmitted by rodents could also be transmitted to people indirectly via ticks, mites, or fleas eaten on an infected rat.

Get Sample Copy of Anticoagulant Rodenticides Market Report @ https://www.polarismarketresearch.com/industry-analysis/anticoagulant-rodenticides-market/request-for-sample

Effective rodent management outside the home is the major technique for preventing human exposure to rodent illnesses. This is accomplished by removing all food sources, closing even the slightest gaps in homes, and successfully capturing rodents in and around the residence. Further, the changing climatic circumstances are significant in the market as global warming changes the population dynamics of rodents and their habitats, as rats breed more prominently in warmer areas.

Climate change is causing a surge in rodent populations, a serious international public health concern. The hantavirus infection is becoming more sensitive to environmental factors. Rodent populations respond more quickly to favorable weather circumstances, such as excessive rainfall, which might directly or indirectly spread rodent-borne infections such as spirosis zoonotic bacterial disease with an undetermined but likely significant human and veterinary frequency.

Need More Information? Inquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/anticoagulant-rodenticides-market/inquire-before-buying

Based on the product, the 1st generation anticoagulants rodenticides market segment accounted for the leading share in the market in 2021. Because of its capacity to break down faster than 2nd generation anticoagulants rodenticides, the first-generation rodenticides product type category accounted for a significant revenue share. The future market expansion of first and second-generation rodenticides, both quantity and income, is strongly related to consumer awareness of good manufacturing practices and government regulations.

Market players such as NEOGEN Corporation, Bayer AG, Bell Labs., Heranba Industries Ltd., Kalyani Industries Limited, BASF SE, Syngenta Crop Protection AG, PelGar International, Rentokil Initial plc, Liphatech, Inc., and UPL are key players operating in the global anticoagulant rodenticides industry.

In May 2021, BASF introduced Selontra, a novel rodenticide bait that it claims can reduce rodent infections in just seven days. The bait contains cholecalciferol, a novel active mechanism of action to which mice are not known to be resistant. Cholecalciferol has a rapid onset of action and stops mouse feeding within 24 hours. This reduces feed wastage and the biosecurity danger posed by rats in agriculture. Concerns about resistance to anticoagulant rodenticides baits necessitated the development of a new action to combat so-called "super rats" that had limited access to difenacoum and bromadiolone active ingredients, which are used in a variety of conventional baits.

Anticoagulant Rodenticides Market report with depth TOC@ https://www.polarismarketresearch.com/industry-analysis/anticoagulant-rodenticides-market

Polaris Market Research has segmented the anticoagulant rodenticides market report based on product, form, application, and region:

Anticoagulant Rodenticides, Product Outlook (Revenue - USD Million, 2018 - 2030)
• 1st Generation Anticoagulants
• 2nd Generation Anticoagulants

Anticoagulant Rodenticides, Form Outlook (Revenue - USD Million, 2018 - 2030)
• Pellets
• Blocks
• Powders & Sprays

Anticoagulant Rodenticides, Application Outlook (Revenue - USD Million, 2018 - 2030)
• Agriculture
• Pest Control Companies
• Warehouses
• Urban Centers
• Household
• Others

Contact Us:
Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

About Us:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defense, among different ventures, present globally.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anticoagulant Rodenticides Market Will Grow USD 921.56 Million By 2030 | CAGR: 3.5% here

News-ID: 2728852 • Views:

More Releases from Polaris Market Research & Consulting

Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of 5.2%
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of …
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors. Market at a Glance In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. It
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 Billion by 2034, Growing at a CAGR of 7.5%
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 …
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 3.82 billion in 2024 and is expected to
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expanding at a CAGR of 6.8%
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin …
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billion
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2034, Growing at a CAGR of 7.44%
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 …
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 31.67 billion in 2024 and is expected to reach

All 5 Releases


More Releases for Anticoagulant

Peptide Anticoagulant Drugs Market Massive Growth opportunity Ahead
Peptide Anticoagulant Drugs market Size, Status, and Forecast for the 2025-2034. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Peptide Anticoagulant Drugs Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply
Anticoagulant Rodenticides Market Is Expanding So Quickly
USD Analytics Market recently introduced Global Anticoagulant Rodenticides Market study with 65+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2024-2032). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are BASF, Bayer, Syngenta, Rentokil, LiphaTech, JT Eaton, Bell Laboratories,
Anticoagulant Reversal Drugs Market In-Depth Analysis 2029
Fairfield Market Research offers a complete understanding of the Global Anticoagulant Reversal Drugs Market in its latest research report. The report includes an unbiased analysis of the market dynamics. The report covers growth prospects, market development potential, product profitability, supply and demand curves and predictions, and government policies. The report has been put together using reliable tools to assess the primary and secondary data. The data is represented in the
Anticoagulant Treatment Market 2021 | Detailed Report
The Anticoagulant Treatment market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Anticoagulant Treatment report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4988667 The Anticoagulant Treatment research report also provides
Anticoagulants Market To See Record Break Revenue $43.42 Million By 2025 | Vitam …
Anticoagulants are medicinal substances that reduce the coagulation of blood and prolong the clotting time. Anticoagulant drugs achieve their effects by suppressing the synthesis or function of various clotting factors that exist in the blood. The global anticoagulants market is anticipated to show significant market growth during the forecast period, owing to increase in prevalence of ischemic heart disease and venous thromboembolism (VTE) and awareness of novel oral anticoagulants (NOACs).
Anticoagulant Drugs Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Anticoagulant Drugs market. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/241687/global-anticoagulant-drugs-market Global Anticoagulant Drugs Market: Forecast by Type / Application / Region Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time. According to this study, over the next five years the Anticoagulant Drugs